MD
Maryland House Bill HB127

Maryland 2024 Regular Session

Maryland House Bill HB127 Compare Versions

OldNewDifferences
1- WES MOORE, Governor Ch. 753
21
3-– 1 –
4-Chapter 753
5-(House Bill 127)
62
7-AN ACT concerning
3+EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
4+ [Brackets] indicate matter deleted from existing law.
5+ Underlining indicates amendments to bill.
6+ Strike out indicates matter stricken from the bill by amendment or deleted from the law by
7+amendment.
8+ *hb0127*
89
9-Public Health – Nonoccupational Postexposure Prophylaxis (nPEP) Standing
10-Order Program – Establishment
10+HOUSE BILL 127
11+J1, J2 4lr0194
12+ (PRE–FILED) CF SB 246
13+By: Chair, Health and Government Operations Committee (By Request –
14+Departmental – Health)
15+Requested: September 13, 2023
16+Introduced and read first time: January 10, 2024
17+Assigned to: Health and Government Operations
18+Committee Report: Favorable with amendments
19+House action: Adopted
20+Read second time: February 23, 2024
1121
12-FOR the purpose of establishing the Nonoccupational Postexposure Prophylaxis (nPEP)
13-Standing Order Program to authorize pharmacists and health care providers to
14-prescribe or dispense nPEP under certain circumstances; authorizing the Maryland
15-Department of Health to administer the Program, collect fees necessary for the
16-administration of the Program, and establish guidelines for training related to the
17-Program; and generally relating to the Nonoccupational Postexposure Prophylaxis
18-(nPEP) Standing Order Program.
22+CHAPTER ______
1923
20-BY adding to
21- Article – Health – General
22-Section 13–5201 through 13–5205 13–5203 to be under the new subtitle “Subtitle 52.
23-Nonoccupational Postexposure Prophylaxis (nPEP) Standing Order Program”
24- Annotated Code of Maryland
25- (2023 Replacement Volume)
24+AN ACT concerning 1
2625
27-BY repealing and reenacting, without amendments,
28- Article – Health Occupations
29- Section 12–101(a)
30- Annotated Code of Maryland
31- (2021 Replacement Volume and 2023 Supplement)
26+Public Health – Nonoccupational Postexposure Prophylaxis (nPEP) Standing 2
27+Order Program – Establishment 3
3228
33-BY repealing and reenacting, with amendments,
34- Article – Health Occupations
35- Section 12–101(x)
36- Annotated Code of Maryland
37- (2021 Replacement Volume and 2023 Supplement)
29+FOR the purpose of establishing the Nonoccupational Postexposure Prophylaxis (nPEP) 4
30+Standing Order Program to authorize pharmacists and health care providers to 5
31+prescribe or dispense nPEP under certain circumstances; authorizing the Maryland 6
32+Department of Health to administer the Program, collect fees necessary for the 7
33+administration of the Program, and establish guidelines for training related to the 8
34+Program; and generally relating to the Nonoccupational Postexposure Prophylaxis 9
35+(nPEP) Standing Order Program. 10
3836
39- SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
40-That the Laws of Maryland read as follows:
37+BY adding to 11
38+ Article – Health – General 12
39+Section 13–5201 through 13–5205 13–5203 to be under the new subtitle “Subtitle 52. 13
40+Nonoccupational Postexposure Prophylaxis (nPEP) Standing Order Program” 14
41+ Annotated Code of Maryland 15
42+ (2023 Replacement Volume) 16
4143
42-Article – Health – General
44+BY repealing and reenacting, without amendments, 17
45+ Article – Health Occupations 18
46+ Section 12–101(a) 19
47+ Annotated Code of Maryland 20
48+ (2021 Replacement Volume and 2023 Supplement) 21 2 HOUSE BILL 127
4349
44-SUBTITLE 52. NONOCCUPAT IONAL POSTEXPOSURE PROPHYLAXIS (NPEP)
45-STANDING ORDER PROGRAM.
4650
47-13–5201.
48- Ch. 753 2024 LAWS OF MARYLAND
4951
50-– 2 –
51- (A) IN THIS SUBTITLE THE FOLLOWING WORDS HAVE THE MEANINGS
52-INDICATED.
52+BY repealing and reenacting, with amendments, 1
53+ Article – Health Occupations 2
54+ Section 12–101(x) 3
55+ Annotated Code of Maryland 4
56+ (2021 Replacement Volume and 2023 Supplement) 5
5357
54- (B) “BOARD” MEANS THE STATE BOARD OF PHARMACY.
58+ SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MA RYLAND, 6
59+That the Laws of Maryland read as follows: 7
5560
56- (C) “CDC GUIDELINES” MEANS THE “UPDATED GUIDELINES FOR
57-ANTIRETROVIRAL POSTEXPOSURE PROPHYLAXIS AFTER SEXUAL, INJECTION
58-DRUG USE, OR OTHER NONOCCUPATIONAL EXPOSURE TO HIV – UNITED STATES
59-2016” OR ANY SUBSEQUENT GU IDELINES PUBLISHED B Y THE CENTERS FOR
60-DISEASE CONTROL AND PREVENTION.
61+Article – Health – General 8
6162
62- (D) “NONOCCUPATIONAL POSTE XPOSURE PROPHYLAXIS ” OR “NPEP”
63-MEANS MEDICATION USE D IN ACCORDANCE WITH THE MOST RECENT CDC
64-GUIDELINES TO REDUCE THE CHANCES OF A PAT IENT DEVELOPING HIV AFTER
65-POTENTIAL EXPOSURE T O THE DISEASE.
63+SUBTITLE 52. NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS (NPEP) 9
64+STANDING ORDER PROGRAM. 10
6665
67- (E) “PHARMACIST” MEANS A PHARMACIST L ICENSED IN THE STATE UNDER
68-TITLE 12 OF THE HEALTH OCCUPATIONS ARTICLE.
66+13–5201. 11
6967
70- (F) “PRIVATE OR PUBLIC ENT ITY” MEANS A HEALTH CARE PROVIDER,
71-LOCAL HEALTH DEPARTM ENT, COMMUNITY –BASED ORGANIZATION , OR OTHER
72-PERSON THAT ADDRESSE S MEDICAL OR SOCIAL ISSUE S RELATED TO HIV
73-EXPOSURE.
68+ (A) IN THIS SUBTITLE THE FOLLOWING WORDS HAVE THE MEANINGS 12
69+INDICATED. 13
7470
75- (G) (F) “PROGRAM” MEANS THE NONOCCUPATIONAL POSTEXPOSURE
76-PROPHYLAXIS (NPEP) STANDING ORDER PROGRAM.
71+ (B) “BOARD” MEANS THE STATE BOARD OF PHARMACY. 14
7772
78- (H) (G) “STANDING ORDER ” MEANS A DIRECTIVE AU THORIZING
79-PHARMACISTS AND HEALTH CARE PROV IDERS TO DISPENSE THE N PEP REGIMENS
80-LISTED IN THE ORDER WITHOUT A PRESCRIPTI ON.
73+ (C) “CDC GUIDELINES” MEANS THE “UPDATED GUIDELINES FOR 15
74+ANTIRETROVIRAL POSTEXPOSURE PROPHYLAXIS AFTER SEXUAL, INJECTION 16
75+DRUG USE, OR OTHER NONOCCUPATIONAL EXPOSURE TO HIV – UNITED STATES 17
76+2016” OR ANY SUBSEQUENT GU IDELINES PUBLISHED BY THE CENTERS FOR 18
77+DISEASE CONTROL AND PREVENTION. 19
8178
82-13–5202.
79+ (D) “NONOCCUPATIONAL POSTE XPOSURE PROPHYLAXIS ” OR “NPEP” 20
80+MEANS MEDICATION USE D IN ACCORDANCE WITH THE MOST RECENT CDC 21
81+GUIDELINES TO REDUCE THE CHANCES OF A PAT IENT DEVELOPING HIV AFTER 22
82+POTENTIAL EXPOSURE T O THE DISEASE. 23
8383
84- (A) THERE IS A NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS
85-(NPEP) STANDING ORDER PROGRAM.
84+ (E) “PHARMACIST” MEANS A PHARMACIST L ICENSED IN THE STATE UNDER 24
85+TITLE 12 OF THE HEALTH OCCUPATIONS ARTICLE. 25
8686
87- (B) THE PROGRAM SHALL :
87+ (F) “PRIVATE OR PUBLIC ENT ITY” MEANS A HEALTH CARE PROVIDER, 26
88+LOCAL HEALTH DEPARTM ENT, COMMUNITY –BASED ORGANIZATION , OR OTHER 27
89+PERSON THAT ADDRESSE S MEDICAL OR SOCIAL ISSUES RELATED TO HIV 28
90+EXPOSURE. 29
8891
89- (1) AUTHORIZE A PHARMACIS T WHO IS REGISTERED WITH THE
90-PROGRAM TO DISPENSE N PEP THROUGH A STANDING O RDER IN ACCORDANCE
91-WITH § 13–5203 OF THIS SUBTITLE; AND
92- WES MOORE, Governor Ch. 753
92+ (G) (F) “PROGRAM” MEANS THE NONOCCUPATIONAL POSTEXPOSURE 30
93+PROPHYLAXIS (NPEP) STANDING ORDER PROGRAM. 31
94+ HOUSE BILL 127 3
9395
94-– 3 –
95- (2) AUTHORIZE A LICENSED HEALTH CARE PROVIDER WITH
96-PRESCRIBING AUTHORIT Y TO PRESCRIBE AND D ISPENSE NPEP THROUGH A
97-STANDING ORDER IN AC CORDANCE WITH § 13–5204 OF THIS SUBTITLE ; AND
9896
99- (3) OPERATE IN ACCORDANCE WITH THE PROCEDURES APPROVED BY
100-THE DEPARTMENT WITH THE A DVICE AND APPROVAL O F THE BOARD.
97+ (H) (G) “STANDING ORDER ” MEANS A DIRECTIVE AU THORIZING 1
98+PHARMACISTS AND HEALTH CARE PROV IDERS TO DISPENSE THE N PEP REGIMENS 2
99+LISTED IN THE ORDER WITHOUT A PRESCRIPTI ON. 3
101100
102- (C) THE DEPARTMENT SHALL ADOP T REGULATIONS NECESSARY:
101+13–5202. 4
103102
104- (1) NECESSARY FOR THE ADMINISTRATI ON OF THE PROGRAM; AND
103+ (A) THERE IS A NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS 5
104+(NPEP) STANDING ORDER PROGRAM. 6
105105
106- (2) THAT ADDRESS THE NEED S OF SPECIFIC POPULA TIONS
107-INCLUDING VICTIMS OF SEXUAL ASSAULT AND P EDIATRIC PATIENTS .
106+ (B) THE PROGRAM SHALL : 7
108107
109- (D) THE DEPARTMENT MAY :
108+ (1) AUTHORIZE A PHARMACIS T WHO IS REGISTERED WITH THE 8
109+PROGRAM TO DISPENSE N PEP THROUGH A STANDING O RDER IN ACCORDANCE 9
110+WITH § 13–5203 OF THIS SUBTITLE; AND 10
110111
111- (1) COLLECT FEES NECESSAR Y FOR THE ADMINISTRA TION OF THE
112-PROGRAM, UNLESS THE PATIENT Q UALIFIES FOR NPEP THROUGH THE PROGRAM
113-FOR PREVENTING HIV INFECTION FOR RAPE VICTIMS ESTABLISHED U NDER §
114-11–1008 OF THE CRIMINAL PROCEDURE ARTICLE;
112+ (2) AUTHORIZE A LICENSED HEALTH CARE PROVIDER WITH 11
113+PRESCRIBING AUTHORIT Y TO PRESCRIBE AND D ISPENSE NPEP THROUGH A 12
114+STANDING ORDER IN AC CORDANCE WITH § 13–5204 OF THIS SUBTITLE ; AND 13
115115
116- (2) ADMINISTER THE PROGRAM AND ESTABLISH A STANDARDIZED
117-SET OF GUIDELINES FO R PRIVATE AND PUBLIC E NTITIES PHARMACISTS
118-PARTICIPATING IN THE PROGRAM TO USE IN DEV ELOPING AND CONDUCTI NG
119-PATIENT EDUCATION AN D TRAINING ON NPEP THAT INCLUDES :
116+ (3) OPERATE IN ACCORDANCE WITH THE PROCEDURES APPROVED BY 14
117+THE DEPARTMENT WITH THE A DVICE AND APPROVAL O F THE BOARD. 15
120118
121- (I) AVOIDING EXPOSURE TO HIV;
119+ (C) THE DEPARTMENT SHALL ADOP T REGULATIONS NECESSARY: 16
122120
123- (II) RESPONDING TO EXPOSUR E TO HIV WITH THE
124-APPROPRIATE USE OF N PEP;
121+ (1) NECESSARY FOR THE ADMINISTRATI ON OF THE PROGRAM; AND 17
125122
126- (III) ACCESS TO NPEP AND THE APPROPRIATE FOLLO W–UP
127-AFTER THE ADMINISTRA TION OF NPEP; AND
123+ (2) THAT ADDRESS THE NEED S OF SPECIFIC POPULA TIONS 18
124+INCLUDING VICTIMS OF SEXUAL ASSAULT AND P EDIATRIC PATIENTS . 19
128125
129- (IV) ENGAGEMENT IN ADDITIO NAL CARE INCLUDING :
126+ (D) THE DEPARTMENT MAY : 20
130127
131- 1. ACCESS TO PRE –EXPOSURE PROPHYLAXIS (PREP);
132-AND
128+ (1) COLLECT FEES NECESSAR Y FOR THE ADMINISTRA TION OF THE 21
129+PROGRAM, UNLESS THE PATIENT Q UALIFIES FOR NPEP THROUGH THE PROGRAM 22
130+FOR PREVENTING HIV INFECTION FOR RAPE VICTIMS ESTABLISHED U NDER § 23
131+11–1008 OF THE CRIMINAL PROCEDURE ARTICLE; 24
133132
134- 2. HARM REDUCTION PROGRA MS FOR PATIENTS WITH
135-CONTINUING RISK OF E XPOSURES; AND
133+ (2) ADMINISTER THE PROGRAM AND ESTABLISH A STANDARDIZED 25
134+SET OF GUIDELINES FO R PRIVATE AND PUBLIC E NTITIES PHARMACISTS 26
135+PARTICIPATING IN THE PROGRAM TO USE IN DEV ELOPING AND CONDUCTI NG 27
136+PATIENT EDUCATION AN D TRAINING ON NPEP THAT INCLUDES : 28
136137
137- (3) COLLECT AND REPORT DA TA ON THE OPERATION AND RESULTS
138-OF THE PROGRAM. Ch. 753 2024 LAWS OF MARYLAND
138+ (I) AVOIDING EXPOSURE TO HIV; 29
139+ 4 HOUSE BILL 127
139140
140-– 4 –
141141
142-13–5203.
142+ (II) RESPONDING TO EXPOSUR E TO HIV WITH THE 1
143+APPROPRIATE USE OF N PEP; 2
143144
144- (A) AT THE TIME OF DISPEN SING NPEP, A PHARMACIST REGISTE RED WITH
145-THE PROGRAM SHALL :
145+ (III) ACCESS TO NPEP AND THE APPROPRIATE FOLLOW–UP 3
146+AFTER THE ADMINISTRA TION OF NPEP; AND 4
146147
147- (1) SCREEN THE PATIENT TO DETERMINE THAT HIV EXPOSURE
148-OCCURRED WITHIN 72 HOURS BEFORE THE DISPENSING ;
148+ (IV) ENGAGEMENT IN ADDITIO NAL CARE INCLUDING : 5
149149
150- (2) DETERMINE WHETHER THE PATIENT MEETS CLINIC AL CRITERIA
151-CONSISTENT WITH THE MOST RECENT CDC GUIDELINES, INCLUDING THE:
150+ 1. ACCESS TO PRE –EXPOSURE PROPHYLAXIS (PREP); 6
151+AND 7
152152
153- (I) THE IDENTIFICATION OF AN Y CONTRAINDICATED
154-MEDICATIONS ; AND
153+ 2. HARM REDUCTION PROGRA MS FOR PATIENTS WITH 8
154+CONTINUING RISK OF E XPOSURES; AND 9
155155
156- (II) IF APPLICABLE, EXPOSURE AS THE RESU LT OF AN ALLEGED
157-RAPE OR SEXUAL OFFEN SE OR ALLEGED CHILD SEXUAL ABUSE ;
156+ (3) COLLECT AND REPORT DA TA ON THE OPERATION AND RESULTS 10
157+OF THE PROGRAM. 11
158158
159- (3) SUBJECT TO SUBSECTION (B) OF THIS SECTION , DETERMINE
160-WHETHER AN AVAILABLE STANDING ORDER IS AP PROPRIATE FOR THE PA TIENT AND
161-DISPENSE NPEP IN ACCORDANCE WITH THE MOST RECENT CDC GUIDELINES;
159+13–5203. 12
162160
163- (4) REFER THE PATIENT TO A DISEASE INTERVENTI ON SPECIALIST
164-WITHIN THE DEPARTMENT FOR ONGOIN G TREATMENT ; AND
161+ (A) AT THE TIME OF DISPEN SING NPEP, A PHARMACIST REG ISTERED WITH 13
162+THE PROGRAM SHALL : 14
165163
166- (5) DETERMINE WHETHER THE PATIENT HAS A PRIMAR Y CARE
167-PROVIDER AND :
164+ (1) SCREEN THE PATIENT TO DETERMINE THAT HIV EXPOSURE 15
165+OCCURRED WITHIN 72 HOURS BEFORE THE DIS PENSING; 16
168166
169- (I) IF THE PATIENT HAS A PRIMARY CARE PROVIDE R, NOTIFY
170-THE PROVIDER THAT THE PA TIENT WAS DISPENSED NPEP; OR
167+ (2) DETERMINE WHETHER THE PATIENT MEETS CLINIC AL CRITERIA 17
168+CONSISTENT WITH THE MOST RECENT CDC GUIDELINES, INCLUDING THE: 18
171169
172- (II) IF THE PATIENT DOES N OT HAVE A PRIMARY CA RE
173-PROVIDER, PROVIDE THE PATIENT WITH A LIST OF LOCAL PRIMARY CARE
174-PROVIDERS AND CLINIC S PROVIDED BY THE DEPARTMENT .
170+ (I) THE IDENTIFICATION OF AN Y CONTRAINDICATED 19
171+MEDICATIONS ; AND 20
175172
176- (B) IF AN AVAILABLE STAND ING ORDER IS NOT APPROPRIATE FOR THE
177-PATIENT, THE PHARMACIST SHALL REFER THE PATIENT TO A PRIMARY CARE
178-PROVIDER.
173+ (II) IF APPLICABLE, EXPOSURE AS THE RESU LT OF AN ALLEGED 21
174+RAPE OR SEXUAL OFFEN SE OR ALLEGED CHILD SEXUAL ABUSE ; 22
179175
180- (C) A PHARMACIST MAY DISPE NSE NPEP IN ACCORDANCE WITH A THERAPY
181-MANAGEMENT CONTRACT UNDER TITLE 12, SUBTITLE 6A OF THE HEALTH
182-OCCUPATIONS ARTICLE.
176+ (3) SUBJECT TO SUBSECTION (B) OF THIS SECTION , DETERMINE 23
177+WHETHER AN AVAILABLE STANDING ORDER IS AP PROPRIATE FOR THE PA TIENT AND 24
178+DISPENSE NPEP IN ACCORDANCE WITH THE MOST RECENT CDC GUIDELINES; 25
183179
184-13–5204. WES MOORE, Governor Ch. 753
180+ (4) REFER THE PATIENT TO A DISEASE INTERVENTI ON SPECIALIST 26
181+WITHIN THE DEPARTMENT FOR ONGOIN G TREATMENT ; AND 27
185182
186-– 5 –
183+ (5) DETERMINE WHETHER THE PATIENT HAS A PRIMAR Y CARE 28
184+PROVIDER AND : 29
185+ HOUSE BILL 127 5
187186
188- (A) A LICENSED HEALTH CARE PROVIDER WITH PRESCR IBING AUTHORITY
189-WHO IS REGISTERED WI TH THE PROGRAM MAY DELEGATE THE DISPENSING OF
190-NPEP UNDER A STANDING ORD ER TO AN EMPLOYEE OR A VOLUNTEER OF AN
191-AUTHORIZED PRIVATE O R PUBLIC ENTITY IN A CCORDANCE WITH A WRITTEN
192-AGREEMENT UNDER § 13–5205 OF THIS SUBTITLE.
193187
194- (B) ANY LICENSED HEALTH C ARE PROVIDER WHO HAS DISPENSING
195-AUTHORITY MAY DISPEN SE NPEP TO AN INDIVIDUAL IN ACCORDANCE WITH A
196-STANDING ORDER IN AC CORDANCE WITH THIS S UBSECTION.
188+ (I) IF THE PATIENT HAS A PRIMARY CARE PROVIDE R, NOTIFY 1
189+THE PROVIDER THAT TH E PATIENT WAS DISPEN SED NPEP; OR 2
197190
198-13–5205.
191+ (II) IF THE PATIENT DOES N OT HAVE A PRIMARY CA RE 3
192+PROVIDER, PROVIDE THE PATIENT WITH A LIST OF LOCAL PRIMARY CARE 4
193+PROVIDERS AND CLINIC S PROVIDED BY THE DEPARTMENT . 5
199194
200- AN AUTHORIZED PR IVATE OR PUBLIC ENTI TY SHALL ENTER INTO A WRITTEN
201-AGREEMENT WITH A LIC ENSED HEALTH CARE PR OVIDER WITH PRESCRIB ING
202-AUTHORITY TO ESTABLI SH PROTOCOLS FOR THE PRESCRIBING AND DISP ENSING OF
203-NPEP TO ANY INDIVIDUAL IN ACCORDANCE WITH THIS SUBTITLE.
195+ (B) IF AN AVAILABLE STAND ING ORDER IS NOT APP ROPRIATE FOR THE 6
196+PATIENT, THE PHARMACIST SHALL REFER THE PATIENT TO A P RIMARY CARE 7
197+PROVIDER. 8
204198
205-Article – Health Occupations
199+ (C) A PHARMACIST MAY DISPE NSE NPEP IN ACCORDANCE WITH A THERAPY 9
200+MANAGEMENT CONTRACT UNDER TITLE 12, SUBTITLE 6A OF THE HEALTH 10
201+OCCUPATIONS ARTICLE. 11
206202
207-12–101.
203+13–5204. 12
208204
209- (a) In this title the following words have the meanings indicated.
205+ (A) A LICENSED HEALTH CARE PROVIDER WITH PRESCR IBING AUTHORITY 13
206+WHO IS REGISTERED WI TH THE PROGRAM MAY DELEGATE THE DISPENSING OF 14
207+NPEP UNDER A STANDING ORD ER TO AN EMPLOYEE OR A VOLUNTEER OF AN 15
208+AUTHORIZED PRIVATE O R PUBLIC ENTITY IN A CCORDANCE WITH A WRI TTEN 16
209+AGREEMENT UNDER § 13–5205 OF THIS SUBTITLE. 17
210210
211- (x) (1) “Practice pharmacy” means to engage in any of the following activities:
211+ (B) ANY LICENSED HEALTH C ARE PROVIDER WHO HAS DISPENSING 18
212+AUTHORITY MAY DISPEN SE NPEP TO AN INDIVIDUAL IN ACCORDANCE WITH A 19
213+STANDING ORDER IN AC CORDANCE WITH THIS S UBSECTION. 20
212214
213- (i) Providing pharmaceutical care;
215+13–5205. 21
214216
215- (ii) Compounding, dispensing, or distributing prescription drugs or
216-devices;
217+ AN AUTHORIZED PRIVATE OR PUBLIC ENTITY SHA LL ENTER INTO A WRIT TEN 22
218+AGREEMEN T WITH A LICENSED HE ALTH CARE PROVIDER W ITH PRESCRIBING 23
219+AUTHORITY TO ESTABLI SH PROTOCOLS FOR THE PRESCRIBING AND DISP ENSING OF 24
220+NPEP TO ANY INDIVIDUAL IN ACCORDANCE WITH THIS SUBTITLE. 25
217221
218- (iii) Compounding or dispensing nonprescription drugs or devices;
222+Article – Health Occupations 26
219223
220- (iv) Monitoring prescriptions for prescription and nonprescription
221-drugs or devices;
224+12–101. 27
222225
223- (v) Providing information, explanation, or recommendations to
224-patients and health care practitioners about the safe and effective use of prescription or
225-nonprescription drugs or devices;
226+ (a) In this title the following words have the meanings indicated. 28
226227
227- (vi) Identifying and appraising problems concerning the use or
228-monitoring of therapy with drugs or devices;
228+ (x) (1) “Practice pharmacy” means to engage in any of the following activities: 29
229229
230- (vii) Acting within the parameters of a therapy management contract,
231-as provided under Subtitle 6A of this title; Ch. 753 2024 LAWS OF MARYLAND
230+ (i) Providing pharmaceutical care; 30
231+ 6 HOUSE BILL 127
232232
233-– 6 –
234233
235- (viii) Administering vaccinations in accordance with § 12–508 of this
236-title or self–administered drugs or maintenance injectable medications in accordance with
237-§ 12–509 of this title;
234+ (ii) Compounding, dispensing, or distributing prescription drugs or 1
235+devices; 2
238236
239- (ix) Delegating a pharmacy act to a registered pharmacy technician,
240-pharmacy student, or an individual engaged in a Board approved pharmacy technician
241-training program;
237+ (iii) Compounding or dispensing nonprescription drugs or devices; 3
242238
243- (x) Supervising a delegated pharmacy act performed by a registered
244-pharmacy technician, pharmacy student, or an individual engaged in a Board approved
245-pharmacy technician training program;
239+ (iv) Monitoring prescriptions for prescription and nonprescription 4
240+drugs or devices; 5
246241
247- (xi) Providing drug therapy management in accordance with §
248-19–713.6 of the Health – General Article;
242+ (v) Providing information, explanation, or recommendations to 6
243+patients and health care practitioners about the safe and effective use of prescription or 7
244+nonprescription drugs or devices; 8
249245
250- (xii) Prescribing and dispensing contraceptive medications and
251-self–administered contraceptive devices approved by the U.S. Food and Drug
252-Administration; [or]
246+ (vi) Identifying and appraising problems concerning the use or 9
247+monitoring of therapy with drugs or devices; 10
253248
254- (xiii) Prescribing and dispensing nicotine replacement therapy
255-medications; OR
249+ (vii) Acting within the parameters of a therapy management contract, 11
250+as provided under Subtitle 6A of this title; 12
256251
257- (XIV) IF THE PHARMACIST IS REGISTERED WITH THE
258-NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS (NPEP) STANDING ORDER
259-PROGRAM ESTABLISHED U NDER § 13–5202 OF THE HEALTH – GENERAL ARTICLE,
260-PRESCRIBING AND DISPENSING NONOCCUPA TIONAL POSTEXPOSURE PROPHYLAXIS
261-(NPEP) MEDICATION APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION
262-AND IN ACCORDANCE WI TH “UPDATED GUIDELINES FOR ANTIRETROVIRAL
263-POSTEXPOSURE PROPHYLAXIS AFTER SEXUAL, INJECTION DRUG USE, OR OTHER
264-NONOCCUPATIONAL EXPOSURE TO HIV – UNITED STATES 2016” OR SUBSEQUENT
265-GUIDELINES PUBLISHED BY THE FEDERAL CENTERS FOR DISEASE CONTROL AND
266-PREVENTION.
252+ (viii) Administering vaccinations in accordance with § 12–508 of this 13
253+title or self–administered drugs or maintenance injectable medications in accordance with 14
254+§ 12–509 of this title; 15
267255
268- (2) “Practice pharmacy” does not include the operations of a person who
269-holds a permit issued under § 12–6C–03 of this title.
256+ (ix) Delegating a pharmacy act to a registered pharmacy technician, 16
257+pharmacy student, or an individual engaged in a Board approved pharmacy technician 17
258+training program; 18
270259
271- SECTION 2. AND BE IT FURTHER ENACTED, That t his Act shall take effect
272-October 1, 2024.
260+ (x) Supervising a delegated pharmacy act performed by a registered 19
261+pharmacy technician, pharmacy student, or an individual engaged in a Board approved 20
262+pharmacy technician training program; 21
273263
274-Approved by the Governor, May 16, 2024.
264+ (xi) Providing drug therapy management in accordance with § 22
265+19–713.6 of the Health – General Article; 23
266+
267+ (xii) Prescribing and dispensing contraceptive medications and 24
268+self–administered contraceptive devices approved by the U.S. Food and Drug 25
269+Administration; [or] 26
270+
271+ (xiii) Prescribing and dispensing nicotine replacement therapy 27
272+medications; OR 28
273+
274+ (XIV) IF THE PHARMACIST IS REGISTERED WITH THE 29
275+NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS (NPEP) STANDING ORDER 30
276+PROGRAM ESTABLISHED U NDER § 13–5202 OF THE HEALTH – GENERAL ARTICLE, 31
277+PRESCRIBING AND DISPENSING NONOCCUPA TIONAL POSTEXPOSURE PROPHYLAXIS 32
278+(NPEP) MEDICATION APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION 33
279+AND IN ACCORDANCE WI TH “UPDATED GUIDELINES FOR ANTIRETROVIRAL 34 HOUSE BILL 127 7
280+
281+
282+POSTEXPOSURE PROPHYLAXIS AFTER SEXUAL, INJECTION DRUG USE, OR OTHER 1
283+NONOCCUPATIONAL EXPOSURE TO HIV – UNITED STATES 2016” OR SUBSEQUENT 2
284+GUIDELINES PUBLISHED BY THE FEDERAL CENTERS FOR DISEASE CONTROL AND 3
285+PREVENTION. 4
286+
287+ (2) “Practice pharmacy” does not include the operations of a person who 5
288+holds a permit issued under § 12–6C–03 of this title. 6
289+
290+ SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 7
291+October 1, 2024. 8
292+
293+
294+
295+
296+
297+Approved:
298+________________________________________________________________________________
299+ Governor.
300+________________________________________________________________________________
301+ Speaker of the House of Delegates.
302+________________________________________________________________________________
303+ President of the Senate.